Table III.
IL-1β and HB-EGF levels in serum and follicular fluid of patients in the two groups.
| Serum | |||||
|---|---|---|---|---|---|
| Group | D3 | HCG day | OR day | ET day | FF |
| Implantation group (n=33) | |||||
| IL-1β (ng/ml) | 17.26±7.49 | 162.86±53.27 | 71.21±24.65 | 39.46±28.18 | 67.02±24.20 |
| HB-EGF (pg/ml) | 312.25±255.13 | 323.34±267.17 | 337.28±263.49 | 361.10±285.26 | 350.42±285.26 |
| Non-implantation group (n=39) | |||||
| IL-1β (ng/ml) | 15.32±7.37 | 82.86±35.34 | 33.91±14.53 | 60.46±25.12 | 39.08±18.26 |
| HB-EGF (pg/ml) | 272.28±195.06 | 288.43±207.62 | 295.29±213.87 | 285.14±205.83 | 230±285.26 |
IL-1β, interleukin-1β; HB-EGF, heparin-binding epidermal growth factor; D3, 3rd day in menstrual cycle; HCG day, day of injecting HCG; OR day, day of oocyte retrieval; ET day, day of embryo transfer; FF, follicular fluid.